Immediate Impact
74 standout
Citing Papers
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
2024 Standout
Works of F. Norwood being referenced
Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group
2013
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| F. Norwood | 182 | 35 | 14 | 58 | 38 | 8 | 293 | |
| Jo Stevens | 143 | 19 | 6 | 46 | 11 | 15 | 273 | |
| Paola Vázquez-Cárdenas | 63 | 22 | 38 | 108 | 66 | 11 | 318 | |
| M Salmon | 52 | 36 | 6 | 32 | 15 | 8 | 257 | |
| Charles M. Harper | 130 | 58 | 3 | 132 | 22 | 11 | 325 | |
| Vittorio Gatto | 73 | 21 | 19 | 102 | 17 | 12 | 288 | |
| J B Peiris | 138 | 48 | 22 | 25 | 39 | 14 | 271 | |
| S. Goodburn | 91 | 137 | 158 | 99 | 42 | 12 | 332 | |
| Eva Eliassen | 108 | 25 | 3 | 26 | 11 | 9 | 305 | |
| Deepa Bhattarai | 55 | 8 | 12 | 111 | 56 | 12 | 306 | |
| Šarūnas Tamašauskas | 43 | 7 | 26 | 46 | 38 | 14 | 302 |
All Works
Loading papers...